PREX2 contributes to radiation resistance by inhibiting radiotherapy-induced tumor immunogenicity via cGAS/STING/IFNs pathway in colorectal cancer.
Li M, Xiao J, Song S, Han F, Liu H, Lin Y, Ni Y, Zeng S, Zou X, Wu J, Wang F, Xu S, Liang Y, Xu P, Hong H, Qiu J, Cao J, Zhu Q, Liang L.
Li M, et al. Among authors: ni y.
BMC Med. 2024 Apr 12;22(1):154. doi: 10.1186/s12916-024-03375-2.
BMC Med. 2024.
PMID: 38609982
Free PMC article.